Literature DB >> 949077

Choroidal neovascular membrane in Best's vitelliform macular dystrophy.

S A Miller, G H Bresnick, S R Chandra.   

Abstract

The right eye of a 9-year-old white boy with Best's vitelliform macular dystrophy had an intact egg-yolk lesion and a retinal pigment epithelial defect superiorly, suggesting an early pseudohypopyon stage. The disruptive phase of the left eye showed subretinal hemorrhages, a "signet ring," and a subretinal neovascular membrane.

Entities:  

Mesh:

Year:  1976        PMID: 949077     DOI: 10.1016/0002-9394(76)90428-1

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  12 in total

1.  An unusual presentation of Best's disease.

Authors:  R C Fletcher; L M Jampol; W Rimm
Journal:  Br J Ophthalmol       Date:  1977-11       Impact factor: 4.638

Review 2.  Electrophysiology and inherited retinal disorders.

Authors:  G A Fishman
Journal:  Doc Ophthalmol       Date:  1985-08-30       Impact factor: 2.379

3.  Pseudoinflammatory macular dystrophy.

Authors:  R E Carr; K G Noble
Journal:  Trans Am Ophthalmol Soc       Date:  1977

Review 4.  Molecular genetics of macular degeneration.

Authors:  M A Musarella
Journal:  Doc Ophthalmol       Date:  2001-05       Impact factor: 2.379

5.  Macular lesions secondary to choroidal vascular disorders.

Authors:  S S Hayreh
Journal:  Int Ophthalmol       Date:  1983-02       Impact factor: 2.031

6.  Polymorphous presentations in vitelliform macular dystrophy: subretinal neovascularisation and central choroidal atrophy.

Authors:  K G Noble; B M Scher; R E Carr
Journal:  Br J Ophthalmol       Date:  1978-08       Impact factor: 4.638

7.  Phenotypic variability due to a novel Glu292Lys variation in exon 8 of the BEST1 gene causing best macular dystrophy.

Authors:  Elliott H Sohn; Peter J Francis; Jacque L Duncan; Richard G Weleber; David A Saperstein; Donald F Farrell; Edwin M Stone
Journal:  Arch Ophthalmol       Date:  2009-07

8.  Intravitreal bevacizumab for choroidal neovascular membrane associated with Best's vitelliform dystrophy.

Authors:  Ekta Rishi; Pukhraj Rishi; Sheshadri Mahajan
Journal:  Indian J Ophthalmol       Date:  2010 Mar-Apr       Impact factor: 1.848

9.  New VMD2 gene mutations identified in patients affected by Best vitelliform macular dystrophy.

Authors:  D Marchant; K Yu; K Bigot; O Roche; A Germain; D Bonneau; V Drouin-Garraud; D F Schorderet; F Munier; D Schmidt; P Le Neindre; C Marsac; M Menasche; J L Dufier; R Fischmeister; C Hartzell; M Abitbol
Journal:  J Med Genet       Date:  2007-02-07       Impact factor: 6.318

10.  Subretinal neovascularization in the Vogt-Koyanagi-Harada syndrome.

Authors:  R R Ober; R E Smith; S J Ryan
Journal:  Int Ophthalmol       Date:  1983-06       Impact factor: 2.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.